Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.61 % |
3 Month Return | -9.34 % |
1 Year Return | + 25.28 % |
Market Stats | |
Previous Close | ₹46.98 |
Open | ₹46.98 |
Volume | 773.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹222.28Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹222.28 Cr |
P/B Ratio | 28.26 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹222.28 Cr | 18.51% | 0.96 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Kimia Biosciences Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Kimia Biosciences Ltd
Kimia Biosciences reported a 33.71% increase in topline and a profit of ₹1.8cr for Q4, compared to a loss of ₹6.17cr in the previous year's same period. The revenue grew by 15.9%, while SG&A expenses declined by 10.27% q-o-q & decreased by 29.61% Y-o-Y. Operating income was up by 279.31% q-o-q & increased by 145.96% Y-o-Y. EPS is ₹0.38 for Q4 which increased by 132.26% Y-o-Y. Kimia Biosciences has delivered -2.28% return in the last 1 week, 12.62% return in the last 6 months, and 22.42% YTD return.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 years, Kimia Bioscien. stock has moved up by 16.6%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 33.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.94% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 114.0%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 24.68% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.94% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0.38% | 0.00 | |
Retail Investors | 24.68% | 0.00 | |
Others | 0% | 0.00 |
Kimia Biosciences Ltd’s net profit jumped 165.98% since last year same period to ₹1.61Cr in the Q2 2024-2025. On a quarterly growth basis, Kimia Biosciences Ltd has generated 11.81% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Kimia Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Kimia Biosciences Ltd (530313) share price today is ₹46.29
Kimia Biosciences Ltd is not listed on NSE
Kimia Biosciences Ltd is listed on BSE
Today’s traded volume of Kimia Biosciences Ltd(530313) is 773.00.
Today’s market capitalisation of Kimia Biosciences Ltd(530313) is ₹222.28Cr.
Kimia Biosciences Ltd(530313 | Price |
---|---|
52 Week High | ₹58.4 |
52 Week Low | ₹33.2 |
Kimia Biosciences Ltd(530313) share price is ₹46.29. It is down -20.74% from its 52 Week High price of ₹58.4
Kimia Biosciences Ltd(530313) share price is ₹46.29. It is up 39.43% from its 52 Week Low price of ₹33.2
Kimia Biosciences Ltd(530313 | Returns |
---|---|
1 Day Returns | -0.69% |
1 Month Returns | -4.61% |
3 Month Returns | -9.34% |
1 Year Returns | 25.28% |